InCarda Therapeutics raises $5M for heart treatment in latest round of financing

By Tomas H. Lucero

“Know diseases, known drugs, new delivery.” These are the three tenets of InCarda Therapeutics’ business model. Evidently, it’s working for investors, who have just given the company a vote of confidence by helping it complete its Series A financing.

InCarda has raised over five million with potential tranches totaling $1.5 million more. The lead investor in the financing is Morningside Venture. Other investors include an association of physicians along with other health care and high tech professionals. Reenie McCarthy, representing Morningside, will join InCarda's board of directors. Proceeds from the financing will be used to further the company’s lead cardiovascular program for an inhaled therapy intended to treat paroxysmal atrial fibrillation (PAF).

Grace E. Colon, Phd.D., chief executive officer and president of InCarda is confident that the company’s therapies will influence PAF treatment: "At InCarda, we strongly believe that the concept of inhaled cardiotherapeutics will change the way certain acute cardiovascular conditions are treated today, providing patients with better therapeutic options and resulting in significant savings to the healthcare system."

"This financing will enable us to advance development of our lead product to its next major milestone, a clinical proof-of-concept trial in Australia and also advance other product concepts in our development pipeline. We are so pleased to have the support of such a high-quality group as Morningside as we develop our innovative products,” she added.

"InCarda's focus on improving real-time treatment of acute cardiovascular events addresses a major unmet need," said Reenie McCarthy, for Morningside. "We look forward to supporting InCarda as they advance their products into clinical proof of concept."

Related Story: Is your venture capital on the digital health bandwagon?

Related Story: Developers Search for Venture Capital to Launch App that Will Stop Wheel Theft

Share

Featured Articles

DEI done right: Brook Sims, COO, MAC Diversity Recruiters

Passionate about helping others find their voice, diversity leader and COO Brook Sims talks powerful leadership, diverse teams and being a change agent

Q&A: China’s ecommerce innovator Jeff Li, CEO of Shoplazza

Named in Fortune China’s 40 under 40 for 2022, former Baidu head Jeff Li is the entrepreneurial founder and CEO of ecommerce platform Shoplazza

How hybrid work is revolutionising the physical office

As hybrid work models roll out worldwide, the purpose of the office is changing with collaboration, connection and networking taking centre stage

Trailblazer: Shanique Bonelli-Moore, DEI chief at Clorox

Sustainability

Dean Forbes – the Forterro CEO aiming for the moon

Leadership & Strategy

Why becoming a B Corp is good for business

Sustainability